- Home
- EQH vs SLRX Comparison
EQH vs SLRX Comparison
Compare EQH & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQH
- SLRX
- Stock Information
- Founded
- EQH 1859
- SLRX N/A
- Country
- EQH United States
- SLRX United States
- Employees
- EQH N/A
- SLRX N/A
- Industry
- EQH Specialty Insurers
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- EQH Finance
- SLRX Health Care
- Exchange
- EQH Nasdaq
- SLRX Nasdaq
- Market Cap
- EQH N/A
- SLRX 1.8M
- IPO Year
- EQH N/A
- SLRX N/A
- Fundamental
- Price
- EQH $51.85
- SLRX $0.68
- Analyst Decision
- EQH Strong Buy
- SLRX
- Analyst Count
- EQH 10
- SLRX 0
- Target Price
- EQH $65.30
- SLRX N/A
- AVG Volume (30 Days)
- EQH 2.7M
- SLRX 3.6M
- Earning Date
- EQH 08-05-2025
- SLRX 08-08-2025
- Dividend Yield
- EQH 2.07%
- SLRX N/A
- EPS Growth
- EQH 13.70
- SLRX N/A
- EPS
- EQH 3.76
- SLRX N/A
- Revenue
- EQH $15,105,000,000.00
- SLRX N/A
- Revenue This Year
- EQH $19.33
- SLRX N/A
- Revenue Next Year
- EQH $0.28
- SLRX N/A
- P/E Ratio
- EQH $13.89
- SLRX N/A
- Revenue Growth
- EQH 45.39
- SLRX N/A
- 52 Week Low
- EQH $36.46
- SLRX $0.45
- 52 Week High
- EQH $56.61
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- EQH 39.90
- SLRX 37.80
- Support Level
- EQH $54.39
- SLRX $0.64
- Resistance Level
- EQH $56.42
- SLRX $0.90
- Average True Range (ATR)
- EQH 1.13
- SLRX 0.11
- MACD
- EQH -0.41
- SLRX -0.03
- Stochastic Oscillator
- EQH 0.21
- SLRX 6.92
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.